I
IKang Healthcare Group
Ikang is a Chinese health management service agency providing personalized health-related services
About IKang Healthcare Group
iKang Healthcare Group, established in 2004 by serial entrepreneur Lee Ligang Zhang, operates as a prominent provider in China's private preventive healthcare sector. Zhang, who serves as Chairman and CEO, brought a blend of internet and healthcare experience to the venture, having previously co-founded the online travel service eLong.com and worked at Sohu.com. His academic background includes a bachelor's degree in biology and chemistry from Concordia College and a master's in genetics from Harvard Medical School, which provided a strong foundation for his vision to merge healthcare delivery with a versatile online platform.
The company was founded with the goal of creating a nationwide, accessible network for preventative health services. Its business model focuses on providing comprehensive health management services to a client base that primarily consists of corporate customers contracting for their employees, as well as individual consumers. iKang generates revenue by offering services such as medical examinations, disease screening, dental care, and other value-added healthcare solutions. The company serves approximately 10 million individuals annually through its network of medical centers.
iKang provides a suite of services that includes health checkups, disease screening with a focus on cancer and cardiovascular conditions, dental services, and outpatient care. A key aspect of its operations is the integration of technology, evolving from an online platform to an AI-driven, cloud-based health management system. The company launched the iKangAI+ platform in 2018, using artificial intelligence for real-time image analysis in screening and diagnosis. Specialized offerings include the iKang MRI Centre for full-body cancer screening and the iKang Cardiac Rehabilitation Centre, established in 2022, which integrates health examinations with rehabilitation services. In 2017, the company launched its iKangCare+ and iKangPartners+ strategic initiatives to enhance corporate client services through AI and improved follow-up care.
The company has undergone significant corporate evolution, including its listing on the NASDAQ in April 2014 under the ticker KANG. A major milestone was its privatization in January 2019, a move completed through a merger with a buyer group that included Yunfeng Capital and Alibaba Group in a transaction valued at approximately $1.5 billion. The company has received recognition for its services, including being named Diagnostics Provider of the Year and Specialty Clinic of the Year in China at the 2025 Healthcare Asia Awards.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 59
- Open positions
- 42
- Dealroom signal
- 30.4/100
- Industry
- Wellness Beauty
- Client focus
- B2B
- Investment activity
- 2 companies, latest Jul 2015
- Capital deployed
- $4.8M
- Preferred round
- SERIES A
- Links
- Website
News
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| IPOOther financing | Apr 2014 | $40M | — | China Investment Corporation | — |
| GROWTH EQUITY VCOther financing | May 2013 | $100M | — | Goldman Sachs · GIC | — |
Growth signals
Latest recorded traffic for IKang Healthcare Group is 4.4K monthly website visits, down 29% over the last three months. IKang Healthcare Group's team grew 0% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Welkin HealthSan Francisco, United StatesDigital patient relationship platform
$70Mvaluation
YJ
Yixue JieHuangpu, ChinaOnline platform providing medical content and clinical tools
→
IKang Healthcare Group in the Dongcheng District ecosystem
The IKang Healthcare Group office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later2 investors entered at this stage
Other known investors1 additional known investor
China Investment Corporation
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about IKang Healthcare Group on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See IKang Healthcare Group’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









